Data Foundry

Drug recalls 2015

5% Dextrose Injection — Class II drug recall D-0426-2015

Terminated recall by Baxter Healthcare Corp., reported 2015-04-01, distributed nationwide. Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise

Recall numberD-0426-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBaxter Healthcare Corp., Deerfield, IL, United States
Recall initiated2015-03-18
Classified2015-03-25
Reported by FDA2015-04-01
Terminated2016-02-24
DistributedNationwide (US)
Quantity48,874
Reason classessterility, packaging
NDC00338-0017, 00338-0017-02, 00338-0017-03, 00338-0017-04, 00338-0017-10, 00338-0017-11, 00338-0017-18, 00338-0017-31, 00338-0017-38, 00338-0017-41, 00338-0017-48, 00338-0023, 00338-0023-02, 00338-0023-03, 00338-0023-04
Lot numbersC926899
Expiration dates2015-07-31

Product

5% Dextrose Injection, USP, 1000mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC 0338-0017-04

Reason for recall

Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0426-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.